Stock market crash: I’d invest £3k in these 2 cheap UK shares in an ISA today to get rich

first_img Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Peter Stephens | Wednesday, 12th August, 2020 | More on: GSK SSE Enter Your Email Address Buying cheap UK shares after the recent market crash could be a means of generating high returns in the long run. Low valuations today, plus a likely stock market recovery, could reward investors who can look beyond risks such as Brexit and the coronavirus pandemic.With that in mind, here are two UK shares that appear to offer a potent mix of dividends, long-term growth potential and attractive valuations. Investing £3k, or any other amount, in them today could help to grow your ISA over the coming years.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…GSK: appealing dividend stock after market crashGSK (LSE: GSK) could offer income investing appeal after the market crash. The company has maintained its dividend thus far at a time when around half of its FTSE 100 peers have decided to cut or delay their shareholder payouts. As such, it could become a more popular income investing opportunity while it offers a yield of 4.8%. This could help to push its share price higher.GSK’s recent half-year results showed that coronavirus has disrupted its vaccines business. However, it expects this challenge to ease during the second half of the year, while it continues to make good progress in its restructuring plans and in developing its pipeline. As such, it may be less affected by a weak economic outlook than many other UK shares, which could provide it with defensive characteristics.Therefore, now could be the right time to buy a slice of the business after the recent market crash. It seems to offer a mix of income appeal, long-term growth potential and defensive characteristics that could equate to impressive total returns from what remains an attractive valuation.SSE: a sound strategy and high yieldSSE (LSE: SSE) is another FTSE 100 stock that could offer an attractive dividend outlook. The company’s recent trading update stated that it plans to stick to its five-year dividend plan whereby it expects to increase dividends per share at a similar pace to inflation. This means that it currently yields around 6%, which could make it a popular income share among investors when many of its index peers are reducing their shareholder payouts.As with many UK shares, coronavirus has impacted SSE’s financial performance. It has faced disruption across some of its businesses, which is a trend that could continue in the near term. However, its £7.5bn capital expenditure programme that is targeted towards low-carbon investments could help to deliver an improving long-term financial outlook for the business, I feel.As such, it could offer a resilient long-term financial performance relative to other UK shares. Although there is a risk of a second market crash, SSE seems to have a sound strategy through which to deliver dividend growth in the coming years. Image source: Getty Images “This Stock Could Be Like Buying Amazon in 1997” Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Our 6 ‘Best Buys Now’ Sharescenter_img Stock market crash: I’d invest £3k in these 2 cheap UK shares in an ISA today to get rich Peter Stephens owns shares of GlaxoSmithKline and SSE. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Simply click below to discover how you can take advantage of this. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. See all posts by Peter Stephenslast_img

Leave a Reply

Your email address will not be published. Required fields are marked *